-
1
-
-
0037724456
-
-
American Cancer Society. Cancer facts and figures 2002. Available at: http://www.cancer.org/eprise/main/docroot/stt/stt_0. Accessed August 10, 2002.
-
(2002)
Cancer Facts and Figures 2002
-
-
-
2
-
-
0031028402
-
Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991
-
Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79(3):564-73.
-
(1997)
Cancer
, vol.79
, Issue.3
, pp. 564-573
-
-
Gilliland, F.D.1
Hunt, W.C.2
Morris, D.M.3
-
3
-
-
0032535770
-
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995
-
Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer 1998;83(12):2638-2648.
-
(1998)
Cancer
, vol.83
, Issue.12
, pp. 2638-2648
-
-
Hundahl, S.A.1
Fleming, I.D.2
Fremgen, A.M.3
-
4
-
-
0026768192
-
The results of various modalities of treatment of well differentiated thyroid carcinoma: A retrospective review of 1599 patients
-
Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75(3):714-20.
-
(1992)
J Clin Endocrinol Metab
, vol.75
, Issue.3
, pp. 714-720
-
-
Samaan, N.A.1
Schultz, P.N.2
Hickey, R.C.3
-
5
-
-
0027135424
-
Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
-
Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114(6):1050-8.
-
(1993)
Surgery
, vol.114
, Issue.6
, pp. 1050-1058
-
-
Hay, I.D.1
Bergstralh, E.J.2
Goellner, J.R.3
-
6
-
-
0019522882
-
Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients
-
Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70(3):511-7.
-
(1981)
Am J Med
, vol.70
, Issue.3
, pp. 511-517
-
-
Mazzaferri, E.L.1
Young, R.L.2
-
7
-
-
0023695539
-
Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
-
Simpson WJ. Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988;14(6):1063-75.
-
(1988)
Int J Radiat Oncol Biol Phys
, vol.14
, Issue.6
, pp. 1063-1075
-
-
Simpson, W.J.1
Panzarella, T.2
Carruthers, J.S.3
-
8
-
-
0024261904
-
Local recurrence in papillary thyroid carcinoma: Is extent of surgical resection important?
-
Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988;104(6):954-62.
-
(1988)
Surgery
, vol.104
, Issue.6
, pp. 954-962
-
-
Grant, C.S.1
Hay, I.D.2
Gough, I.R.3
-
9
-
-
0021992510
-
External radiotherapy in thyroid cancers
-
Tubiana M, Haddad E, Schlumberger M, et al. External radiotherapy in thyroid cancers. Cancer 1985;55(Suppl 9):2062-71.
-
(1985)
Cancer
, vol.55
, Issue.SUPPL. 9
, pp. 2062-2071
-
-
Tubiana, M.1
Haddad, E.2
Schlumberger, M.3
-
10
-
-
0036498574
-
Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy
-
Chow SM, Lw SC, Mendenhall WM, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Rad Oncol Biol Phys 2002;52(3):784-95.
-
(2002)
Int J Rad Oncol Biol Phys
, vol.52
, Issue.3
, pp. 784-795
-
-
Chow, S.M.1
Lw, S.C.2
Mendenhall, W.M.3
-
11
-
-
0023689451
-
Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables
-
Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67(3):501-8.
-
(1988)
J Clin Endocrinol Metab
, vol.67
, Issue.3
, pp. 501-508
-
-
Ruegemer, J.J.1
Hay, I.D.2
Bergstralh, E.J.3
-
12
-
-
0021978711
-
Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients
-
Samaan NA, Schultz PN, Haynie TP, et al. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985;60(2):376-80.
-
(1985)
J Clin Endocrinol Metab
, vol.60
, Issue.2
, pp. 376-380
-
-
Samaan, N.A.1
Schultz, P.N.2
Haynie, T.P.3
-
13
-
-
0023521529
-
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system
-
Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102(6):1088-94.
-
(1987)
Surgery
, vol.102
, Issue.6
, pp. 1088-1094
-
-
Hay, I.D.1
Grant, C.S.2
Taylor, W.F.3
-
14
-
-
0022640101
-
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma?
-
Tennvall J, Biorklund A, Moller T, et al. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Cancer 1986;57(7):1405-14.
-
(1986)
Cancer
, vol.57
, Issue.7
, pp. 1405-1414
-
-
Tennvall, J.1
Biorklund, A.2
Moller, T.3
-
15
-
-
0024232116
-
An expanded view of risk-group definition in differentiated thyroid cancer
-
Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid cancer. Surgery 1988;104(6):947-53.
-
(1988)
Surgery
, vol.104
, Issue.6
, pp. 947-953
-
-
Cady, B.1
Rossi, R.2
-
17
-
-
0031963901
-
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid cancer
-
Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid cancer. Cancer 1998;82(2):375-88.
-
(1998)
Cancer
, vol.82
, Issue.2
, pp. 375-388
-
-
Tsang, R.W.1
Brierley, J.D.2
Simpson, W.J.3
-
18
-
-
0027053161
-
Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period
-
Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;1 12(6):1139-47.
-
(1992)
Surgery
, vol.112
, Issue.6
, pp. 1139-1147
-
-
Hay, I.D.1
Grant, C.S.2
Van Heerden, J.A.3
-
19
-
-
0015413604
-
Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical management
-
Tollefson HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical management. Am J Surg 1972;124(4):468-72.
-
(1972)
Am J Surg
, vol.124
, Issue.4
, pp. 468-472
-
-
Tollefson, H.R.1
Shah, J.P.2
Huvos, A.G.3
-
20
-
-
0027766813
-
Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched pair analysis
-
Shah JP, Loree TR, Dharker D, et al. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched pair analysis. Am J Surg 1993;166(4):331-5.
-
(1993)
Am J Surg
, vol.166
, Issue.4
, pp. 331-335
-
-
Shah, J.P.1
Loree, T.R.2
Dharker, D.3
-
21
-
-
0027943619
-
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
-
Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97(5):418-28.
-
(1994)
Am J Med
, vol.97
, Issue.5
, pp. 418-428
-
-
Mazzaferri, E.L.1
Jhiang, S.M.2
-
22
-
-
0025063417
-
Natural history, treatment, and course of papillary thyroid carcinoma
-
DeGroot LJ, Kaplan EL, McCormick M. Natural history, treatment, and course of papillary thyroid carcinoma. Clin Endocrinol Metab 1990;71(2):414-24.
-
(1990)
Clin Endocrinol Metab
, vol.71
, Issue.2
, pp. 414-424
-
-
DeGroot, L.J.1
Kaplan, E.L.2
McCormick, M.3
-
24
-
-
0036691093
-
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients
-
Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26(8):879-85.
-
(2002)
World J Surg
, vol.26
, Issue.8
, pp. 879-885
-
-
Hay, I.D.1
Thompson, G.B.2
Grant, C.S.3
-
25
-
-
15644367081
-
Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma
-
Taylor T, Specker B, Robbins J, et al. Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998;129(8):622-7.
-
(1998)
Ann Intern Med
, vol.129
, Issue.8
, pp. 622-627
-
-
Taylor, T.1
Specker, B.2
Robbins, J.3
-
26
-
-
0020082525
-
Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation
-
Degroot LJ, Reilly M. Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 1982;96(1):51-3.
-
(1982)
Ann Intern Med
, vol.96
, Issue.1
, pp. 51-53
-
-
Degroot, L.J.1
Reilly, M.2
-
27
-
-
0026071839
-
Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer
-
Johansen K, Woodhouse NJ, Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 1991;32(2):252-4.
-
(1991)
J Nucl Med
, vol.32
, Issue.2
, pp. 252-254
-
-
Johansen, K.1
Woodhouse, N.J.2
Odugbesan, O.3
-
28
-
-
0017170264
-
Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer
-
McCowen KD, Adler RA, Ghaed N, et al. Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer. Am J Med 1976;61(1):52-8.
-
(1976)
Am J Med
, vol.61
, Issue.1
, pp. 52-58
-
-
McCowen, K.D.1
Adler, R.A.2
Ghaed, N.3
-
29
-
-
0022357364
-
Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients
-
Ramanna L, Waxman AD, Brachman MB, et al. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 1985;10(11):791-5.
-
(1985)
Clin Nucl Med
, vol.10
, Issue.11
, pp. 791-795
-
-
Ramanna, L.1
Waxman, A.D.2
Brachman, M.B.3
-
30
-
-
0021750488
-
An analysis "ablation of thyroid remnants" with 1-131 in 511 patients from 1947-1984: Experience at University of Michigan
-
Beierwaltes WH, Rabbani R, Dmuchowski C, et al. An analysis "ablation of thyroid remnants" with 1-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med 1984;25(12):1287-93.
-
(1984)
J Nucl Med
, vol.25
, Issue.12
, pp. 1287-1293
-
-
Beierwaltes, W.H.1
Rabbani, R.2
Dmuchowski, C.3
-
31
-
-
0030001231
-
131I for remnant ablation in patients with differentiated thyroid carcinoma
-
131I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 1996;77(12):2574-80.
-
(1996)
Cancer
, vol.77
, Issue.12
, pp. 2574-2580
-
-
Bal, C.1
Padhy, A.K.2
Jana, S.3
-
32
-
-
0028556247
-
Radioiodine ablation of residual tissue in thyroid cancer: Relationship between administered activity, neck uptake and outcome
-
Logue JP, Tsang RW, Brierley JD, et al. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Br J Radiol 1994;67(803):1127-31.
-
(1994)
Br J Radiol
, vol.67
, Issue.803
, pp. 1127-1131
-
-
Logue, J.P.1
Tsang, R.W.2
Brierley, J.D.3
-
33
-
-
0020518295
-
Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer
-
Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309(16):937-41.
-
(1983)
N Engl J Med
, vol.309
, Issue.16
, pp. 937-941
-
-
Maxon, H.R.1
Thomas, S.R.2
Hertzberg, V.S.3
-
34
-
-
0020595286
-
Thyroid remnant ablation: Questionable pursuit of an ill-defined goal
-
Snyder J, Gorman C, Scanlon P. Thyroid remnant ablation: questionable pursuit of an ill-defined goal. J Nucl Med 1983;24(8):659-65.
-
(1983)
J Nucl Med
, vol.24
, Issue.8
, pp. 659-665
-
-
Snyder, J.1
Gorman, C.2
Scanlon, P.3
-
35
-
-
0036176896
-
Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
-
Berg G, Lindstedt G, Suurküla M, et al. Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone. J Endocrinol Invest 2002;25(1):44-52.
-
(2002)
J Endocrinol Invest
, vol.25
, Issue.1
, pp. 44-52
-
-
Berg, G.1
Lindstedt, G.2
Suurküla, M.3
-
36
-
-
0034858135
-
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin
-
Robbins RJ, Tuttle RM, Sonenberg M, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 2001;11(9):865-9.
-
(2001)
Thyroid
, vol.11
, Issue.9
, pp. 865-869
-
-
Robbins, R.J.1
Tuttle, R.M.2
Sonenberg, M.3
-
37
-
-
0036841049
-
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
-
Robbins RJ, Larson SM, Sinha N, et al. A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. J Nucl Med 2002;43(11):1482-8.
-
(2002)
J Nucl Med
, vol.43
, Issue.11
, pp. 1482-1488
-
-
Robbins, R.J.1
Larson, S.M.2
Sinha, N.3
-
38
-
-
0030030103
-
Differentiated thyroid cancer impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
-
Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996;77(1):172-80.
-
(1996)
Cancer
, vol.77
, Issue.1
, pp. 172-180
-
-
Farahati, J.1
Reiners, C.2
Stuschke, M.3
-
39
-
-
0025214324
-
Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherpy
-
Benker G, Olbricht T, Reinwein D, et al. Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherpy. Cancer 1990;65(7):1517-20.
-
(1990)
Cancer
, vol.65
, Issue.7
, pp. 1517-1520
-
-
Benker, G.1
Olbricht, T.2
Reinwein, D.3
-
40
-
-
0027494285
-
Postoperative irradiation for thyroid cancer
-
Phlips P, Hanzen C, Andry G, et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 1993;19(5):399-404.
-
(1993)
Eur J Surg Oncol
, vol.19
, Issue.5
, pp. 399-404
-
-
Phlips, P.1
Hanzen, C.2
Andry, G.3
-
41
-
-
0028333051
-
Prophylactic external irradiation in differentiated thyroid cancer: A retrospective study over a 30-year observation period
-
Esik O, Nemeth G, Eller J. Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period. Oncology 1994;51(4):372-9.
-
(1994)
Oncology
, vol.51
, Issue.4
, pp. 372-379
-
-
Esik, O.1
Nemeth, G.2
Eller, J.3
-
42
-
-
0028276609
-
Results of external beam radiotherapy in differentiated thyroid carcinoma: A retrospective study from the Royal Marsden Hospital
-
O'Connell ME, A'Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 1994;30A(6):733-9.
-
(1994)
Eur J Cancer
, vol.30 A
, Issue.6
, pp. 733-739
-
-
O'Connell, M.E.1
A'Hern, R.P.2
Harmer, C.L.3
-
43
-
-
0025500636
-
Survival discriminants for differentiated thyroid cancer
-
Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160(4):344-7.
-
(1990)
Am J Surg
, vol.160
, Issue.4
, pp. 344-347
-
-
Cunningham, M.P.1
Duda, R.B.2
Recant, W.3
-
44
-
-
0023901078
-
Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy
-
Rossi RL, Cady B, Silverman ML, et al. Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy. Arch Surg 1988;123(5):569-73.
-
(1988)
Arch Surg
, vol.123
, Issue.5
, pp. 569-573
-
-
Rossi, R.L.1
Cady, B.2
Silverman, M.L.3
-
45
-
-
0029827464
-
Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer
-
Pujol P, Daures JP, Nsakala N, et al. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81(12):4318-4323.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, Issue.12
, pp. 4318-4323
-
-
Pujol, P.1
Daures, J.P.2
Nsakala, N.3
-
46
-
-
0017150624
-
Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma
-
Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184(5):541-53.
-
(1976)
Ann Surg
, vol.184
, Issue.5
, pp. 541-553
-
-
Cady, B.1
Sedgwick, C.E.2
Meissner, W.A.3
-
47
-
-
0021073182
-
The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma
-
Cady B, Cohn K, Rossi RL, et al. The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma. Surgery 1983;94(6):978-83.
-
(1983)
Surgery
, vol.94
, Issue.6
, pp. 978-983
-
-
Cady, B.1
Cohn, K.2
Rossi, R.L.3
-
48
-
-
13144261746
-
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry
-
Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998;8(9):737-44.
-
(1998)
Thyroid
, vol.8
, Issue.9
, pp. 737-744
-
-
Cooper, D.S.1
Specker, B.2
Ho, M.3
-
49
-
-
0019777718
-
The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
-
Ashcraft MW, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 1981;71(5):806-14.
-
(1981)
Am J Med
, vol.71
, Issue.5
, pp. 806-814
-
-
Ashcraft, M.W.1
Van Herle, A.J.2
-
50
-
-
0027233732
-
The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma
-
Dadparvar S, Krishna L, Brady LW, et al. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer 1993;71(11):3767-73.
-
(1993)
Cancer
, vol.71
, Issue.11
, pp. 3767-3773
-
-
Dadparvar, S.1
Krishna, L.2
Brady, L.W.3
-
51
-
-
0031966884
-
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma
-
Gallowitsch HJ, Mikosch P, Kresnik E, et al. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1998;39(5):870-5.
-
(1998)
J Nucl Med
, vol.39
, Issue.5
, pp. 870-875
-
-
Gallowitsch, H.J.1
Mikosch, P.2
Kresnik, E.3
-
52
-
-
0028049352
-
Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma
-
Lubin E, Mechlis-Frish S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994;35(2):257-62.
-
(1994)
J Nucl Med
, vol.35
, Issue.2
, pp. 257-262
-
-
Lubin, E.1
Mechlis-Frish, S.2
Zatz, S.3
-
53
-
-
0025005762
-
Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
-
Ronga G, Fiorentino A, Paserio E, et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?. J Nucl Med 1990;31(11):1766-71.
-
(1990)
J Nucl Med
, vol.31
, Issue.11
, pp. 1766-1771
-
-
Ronga, G.1
Fiorentino, A.2
Paserio, E.3
-
54
-
-
0031742512
-
Thallium-201, technetium-99m-tetrofosmin and iodine131 in detecting differentiated thyroid carcinoma metastases
-
Unal S, Menda Y, Adalet I, et al. Thallium-201, technetium-99m-tetrofosmin and iodine131 in detecting differentiated thyroid carcinoma metastases. J Nucl Med 1998;39(11):1897-902.
-
(1998)
J Nucl Med
, vol.39
, Issue.11
, pp. 1897-1902
-
-
Unal, S.1
Menda, Y.2
Adalet, I.3
-
55
-
-
0028268001
-
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma
-
Sherman SI, Tielens ET, Sostre S, et al. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994;78(3):629-34.
-
(1994)
J Clin Endocrinol Metab
, vol.78
, Issue.3
, pp. 629-634
-
-
Sherman, S.I.1
Tielens, E.T.2
Sostre, S.3
-
56
-
-
0034457145
-
Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
-
Cailleux AF, Baudin E, Travagli JP, et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?. J Clin Endocrinol Metab 2000;85(1):175-8.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, Issue.1
, pp. 175-178
-
-
Cailleux, A.F.1
Baudin, E.2
Travagli, J.P.3
-
57
-
-
0030886175
-
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma
-
Ladenson PW, Braverman LE, Mazzaferri EL, et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 1997;337(13):888-96.
-
(1997)
N Engl J Med
, vol.337
, Issue.13
, pp. 888-896
-
-
Ladenson, P.W.1
Braverman, L.E.2
Mazzaferri, E.L.3
-
58
-
-
0020508474
-
The value of serum thyroglobulin measurement in clinical practice
-
Refetoff S, Lever EG. The value of serum thyroglobulin measurement in clinical practice. JAMA 1983;250(17):2352-7.
-
(1983)
JAMA
, vol.250
, Issue.17
, pp. 2352-2357
-
-
Refetoff, S.1
Lever, E.G.2
-
59
-
-
0021940361
-
Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer
-
Ramanna L, Waxman AD, Brachman MB, et al. Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer. Cancer 1985;55(7):1525-9.
-
(1985)
Cancer
, vol.55
, Issue.7
, pp. 1525-1529
-
-
Ramanna, L.1
Waxman, A.D.2
Brachman, M.B.3
-
60
-
-
0021150692
-
Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma
-
Grant S, Luttrell B, Reeve T, et al. Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma. Cancer 1984;54(8):1625-8.
-
(1984)
Cancer
, vol.54
, Issue.8
, pp. 1625-1628
-
-
Grant, S.1
Luttrell, B.2
Reeve, T.3
-
61
-
-
0025213050
-
Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma
-
Brendel AJ, Lambert B, Guyot M, et al. Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma. Eur J Nucl Med 1990;16(1):35-8.
-
(1990)
Eur J Nucl Med
, vol.16
, Issue.1
, pp. 35-38
-
-
Brendel, A.J.1
Lambert, B.2
Guyot, M.3
-
62
-
-
0023603320
-
Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
-
Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28(12):1888-91.
-
(1987)
J Nucl Med
, vol.28
, Issue.12
, pp. 1888-1891
-
-
Pacini, F.1
Lippi, F.2
Formica, N.3
-
63
-
-
0033341953
-
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
-
Haugen BR, Pacini F, Reiners C. et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999;84(11):3877-85.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, Issue.11
, pp. 3877-3885
-
-
Haugen, B.R.1
Pacini, F.2
Reiners, C.3
-
64
-
-
0031671541
-
Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: Need for thyroglobulin recovery tests
-
Bourrel F, Hoff M, Regis H, et al. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests. Clin Chem Lab Med 1998;36(9):725-30.
-
(1998)
Clin Chem Lab Med
, vol.36
, Issue.9
, pp. 725-730
-
-
Bourrel, F.1
Hoff, M.2
Regis, H.3
-
65
-
-
12244311334
-
Measuring the influence of thyroglobulin autoantibodies on serum thyroglobulin determinations in patients with thyroid carcinoma
-
Robbins R, Fleisher M. Measuring the influence of thyroglobulin autoantibodies on serum thyroglobulin determinations in patients with thyroid carcinoma. Thyroid 1999;9:41A.
-
(1999)
Thyroid
, vol.9
-
-
Robbins, R.1
Fleisher, M.2
-
66
-
-
0022388588
-
Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
-
Pacini F, Lari R, Mazzeo S, et al. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 1985;23(4):405-11.
-
(1985)
Clin Endocrinol (Oxf)
, vol.23
, Issue.4
, pp. 405-411
-
-
Pacini, F.1
Lari, R.2
Mazzeo, S.3
-
67
-
-
0036281001
-
Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
-
Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?. J Clin Endocrinol Metab 2002;87(4):1490-8.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.4
, pp. 1490-1498
-
-
Mazzaferri, E.L.1
Kloos, R.T.2
-
68
-
-
0036280909
-
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment
-
Pacini F, Capezzone M, Elisei R, et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002;87(4):1499-501.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.4
, pp. 1499-1501
-
-
Pacini, F.1
Capezzone, M.2
Elisei, R.3
-
69
-
-
0035098314
-
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma
-
Robbins RJ, Tuttle RM, Sharaf RN, et al. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 2001;86(2):619-25.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, Issue.2
, pp. 619-625
-
-
Robbins, R.J.1
Tuttle, R.M.2
Sharaf, R.N.3
-
70
-
-
0036319730
-
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
-
Robbins RJ, Chon JT, Fleisher M, et al. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 2002;87(7):3242-7.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.7
, pp. 3242-3247
-
-
Robbins, R.J.1
Chon, J.T.2
Fleisher, M.3
-
71
-
-
0023099793
-
Sonography in the follow-up of 100 patients with thyroid carcinoma
-
Simeone JF, Daniels GH, Hall DA, et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 1987;148(1):45-9.
-
(1987)
AJR Am J Roentgenol
, vol.148
, Issue.1
, pp. 45-49
-
-
Simeone, J.F.1
Daniels, G.H.2
Hall, D.A.3
-
72
-
-
85047680822
-
Combination of radioiodine (131I) and probeguided surgery for persistent or recurrent thyroid carcinoma
-
Travagli JP, Cailleux AF, Ricard M, et al. Combination of radioiodine (131I) and probeguided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 1998;83(8):2675-80.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, Issue.8
, pp. 2675-2680
-
-
Travagli, J.P.1
Cailleux, A.F.2
Ricard, M.3
-
73
-
-
0031434133
-
High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer
-
Rodriguez JM, Reus M, Moreno A, et al. High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer. Otolaryngol Head Neck Surg 1997;117(6):694-7.
-
(1997)
Otolaryngol Head Neck Surg
, vol.117
, Issue.6
, pp. 694-697
-
-
Rodriguez, J.M.1
Reus, M.2
Moreno, A.3
-
74
-
-
0035948197
-
Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed
-
Krishnamurthy S, Bedi DG, Caraway NP. Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed. Cancer 2001;93(3):199-205.
-
(2001)
Cancer
, vol.93
, Issue.3
, pp. 199-205
-
-
Krishnamurthy, S.1
Bedi, D.G.2
Caraway, N.P.3
-
75
-
-
0023808716
-
US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer
-
Sutton RT, Reading CC, Charboneau JW, et al. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 1988;168(3):769-72.
-
(1988)
Radiology
, vol.168
, Issue.3
, pp. 769-772
-
-
Sutton, R.T.1
Reading, C.C.2
Charboneau, J.W.3
-
76
-
-
0023683665
-
Recurrent thyroid carcinoma: Characteristics on MR images
-
Auffermann W, Clark OH, Thurnher S, et al. Recurrent thyroid carcinoma: characteristics on MR images. Radiology 1988;168(3):753-7.
-
(1988)
Radiology
, vol.168
, Issue.3
, pp. 753-757
-
-
Auffermann, W.1
Clark, O.H.2
Thurnher, S.3
-
77
-
-
0034754182
-
MRI detection of cervical metastasis from differentiated thyroid carcinoma
-
Gross ND, Weissman JL, Talbot JM, et al. MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope 2001;111(11 pt 1):1905-9.
-
(2001)
Laryngoscope
, vol.111
, Issue.11 PART 1
, pp. 1905-1909
-
-
Gross, N.D.1
Weissman, J.L.2
Talbot, J.M.3
-
78
-
-
0027228504
-
Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy
-
Ohnishi T, Noguchi S, Murakami N, et al. Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy. AJNR Am J Neuroradiol 1993;14(5):1051-7.
-
(1993)
AJNR Am J Neuroradiol
, vol.14
, Issue.5
, pp. 1051-1057
-
-
Ohnishi, T.1
Noguchi, S.2
Murakami, N.3
-
79
-
-
0032231952
-
Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis
-
Takashima S, Sone S, Takayama F, et al. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis. AJNR Am J Neuroradiol 1998;19(3):509-13.
-
(1998)
AJNR Am J Neuroradiol
, vol.19
, Issue.3
, pp. 509-513
-
-
Takashima, S.1
Sone, S.2
Takayama, F.3
-
80
-
-
0034105244
-
Staging papillary carcinoma of the thyroid: Magnetic resonance imaging vs ultrasound of the neck
-
King AD, Ahuja AT, To EW, et al. Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck. Clin Radiol 2000;55(3):222-6.
-
(2000)
Clin Radiol
, vol.55
, Issue.3
, pp. 222-226
-
-
King, A.D.1
Ahuja, A.T.2
To, E.W.3
-
81
-
-
0035218843
-
Advances in the detection of residual thyroid carcinoma
-
Robbins R, Drucker W, Hann L, et al. Advances in the detection of residual thyroid carcinoma. Adv Intern Med 2001;46:277-94.
-
(2001)
Adv Intern Med
, vol.46
, pp. 277-294
-
-
Robbins, R.1
Drucker, W.2
Hann, L.3
-
82
-
-
0030660494
-
Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
-
Dietlein M, Scheidhauer K, Voth E, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997;24(11):1342-8.
-
(1997)
Eur J Nucl Med
, vol.24
, Issue.11
, pp. 1342-1348
-
-
Dietlein, M.1
Scheidhauer, K.2
Voth, E.3
-
83
-
-
0029779869
-
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
-
Feine U, Lietzenmayer R, Hanke JP, et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37(9):1468-72.
-
(1996)
J Nucl Med
, vol.37
, Issue.9
, pp. 1468-1472
-
-
Feine, U.1
Lietzenmayer, R.2
Hanke, J.P.3
-
84
-
-
0029355220
-
18FDG-Ganzkorper-PET bei differenzierten schilddrusenkarzinouen flip flop in speichermuster von 18FDG und 131J
-
Feine U, Lietzenmayer R, Hanke JP, et al. 18FDG-Ganzkorper-PET bei differenzierten schilddrusenkarzinouen flip flop in Speichermuster von 18FDG und 131J [German]. [18FDG whole-body PET in differentiated thyroid carcinoma Flipflop in uptake patterns of 18FDG and 131I]. Nuklearmedizin 1995;34(4):127-34.
-
(1995)
Nuklearmedizin
, vol.34
, Issue.4
, pp. 127-134
-
-
Feine, U.1
Lietzenmayer, R.2
Hanke, J.P.3
-
85
-
-
9044246672
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer
-
Grunwald F, Schomburg A, Bender H, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996;23(3):312-9.
-
(1996)
Eur J Nucl Med
, vol.23
, Issue.3
, pp. 312-319
-
-
Grunwald, F.1
Schomburg, A.2
Bender, H.3
-
86
-
-
0031822670
-
Evaluation of suspected recurrent papillary thyroid carcinoma with [18F] fluorodeoxyglucose positron emission tomography
-
Jadvar H, McDougall IR, Segall GM. Evaluation of suspected recurrent papillary thyroid carcinoma with [18F] fluorodeoxyglucose positron emission tomography. Nucl Med Commun 1998;19(6):547-54.
-
(1998)
Nucl Med Commun
, vol.19
, Issue.6
, pp. 547-554
-
-
Jadvar, H.1
McDougall, I.R.2
Segall, G.M.3
-
87
-
-
0034335410
-
Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer
-
Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 2000;85(3):1107-13.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, Issue.3
, pp. 1107-1113
-
-
Wang, W.1
Larson, S.M.2
Fazzari, M.3
-
88
-
-
0034130683
-
FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma
-
Alnafisi NS, Driedger AA, Coates G, et al. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 2000;41(6):1010-5.
-
(2000)
J Nucl Med
, vol.41
, Issue.6
, pp. 1010-1015
-
-
Alnafisi, N.S.1
Driedger, A.A.2
Coates, G.3
-
89
-
-
0031712448
-
Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans
-
Altenvoerde G, Lerch H, Kuwert T, et al. Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 1998;383(2):160-3.
-
(1998)
Langenbecks Arch Surg
, vol.383
, Issue.2
, pp. 160-163
-
-
Altenvoerde, G.1
Lerch, H.2
Kuwert, T.3
-
90
-
-
0033003175
-
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan
-
Chung JK, So Y, Lee JS, et al. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 1999;40(6):986-92.
-
(1999)
J Nucl Med
, vol.40
, Issue.6
, pp. 986-992
-
-
Chung, J.K.1
So, Y.2
Lee, J.S.3
-
91
-
-
0032871248
-
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography
-
Conti PS, Durski JM, Bacqai F, et al. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 1999;9(8):797-804.
-
(1999)
Thyroid
, vol.9
, Issue.8
, pp. 797-804
-
-
Conti, P.S.1
Durski, J.M.2
Bacqai, F.3
-
92
-
-
0033674689
-
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
-
Frilling A, Gorges R, Tecklenborg K, et al. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 2000;128(6):1067-74.
-
(2000)
Surgery
, vol.128
, Issue.6
, pp. 1067-1074
-
-
Frilling, A.1
Gorges, R.2
Tecklenborg, K.3
-
93
-
-
0032589873
-
Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
-
Grunwald F, Briele B, Biersack HJ. Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?. Q J Nucl Med 1999;43(3):195-206.
-
(1999)
Q J Nucl Med
, vol.43
, Issue.3
, pp. 195-206
-
-
Grunwald, F.1
Briele, B.2
Biersack, H.J.3
-
94
-
-
0031872806
-
Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: Two case reports
-
Huang TS, Chieng PU, Chang CC, et al. Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports. J Endocrinol Invest 1998;21(6):392-8.
-
(1998)
J Endocrinol Invest
, vol.21
, Issue.6
, pp. 392-398
-
-
Huang, T.S.1
Chieng, P.U.2
Chang, C.C.3
-
95
-
-
0033834592
-
Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma
-
Lips P, Comans EF, Hoekstra OS, et al. Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma. Neth J Med 2000;57(4):150-6.
-
(2000)
Neth J Med
, vol.57
, Issue.4
, pp. 150-156
-
-
Lips, P.1
Comans, E.F.2
Hoekstra, O.S.3
-
96
-
-
0033799734
-
Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels
-
Muros MA. Llamas-Elvira JM, Ramirez-Navarro A, et al. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels. Am J Surg 2000;179(6):457-61.
-
(2000)
Am J Surg
, vol.179
, Issue.6
, pp. 457-461
-
-
Muros, M.A.1
Llamas-Elvira, J.M.2
Ramirez-Navarro, A.3
-
97
-
-
0032922782
-
LaPET-FDG en el cencer detiroides ante niveles altos de tiroglobulina y castro 131-I negativo. A proposito de un caso
-
Ortega F, Maldonado A, Maranes P, et al. LaPET-FDG en el cencer detiroides ante niveles altos de tiroglobulina y castro 131-I negativo. A proposito de un caso [Spanish]. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report] Rev Esp Med Nucl 1999;18(1):50-4.
-
(1999)
Rev Esp Med Nucl
, vol.18
, Issue.1
, pp. 50-54
-
-
Ortega, F.1
Maldonado, A.2
Maranes, P.3
-
98
-
-
0033485825
-
The detection of small carcinoma with 18F-FDG using a dual head coincidence camera
-
Stokkel MP, Hoekstra A, van Rijk PP. The detection of small carcinoma with 18F-FDG using a dual head coincidence camera. Eur J Radiol 1999;32(3):160-2.
-
(1999)
Eur J Radiol
, vol.32
, Issue.3
, pp. 160-162
-
-
Stokkel, M.P.1
Hoekstra, A.2
Van Rijk, P.P.3
-
99
-
-
0033237663
-
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels
-
Wang W, Macapinlac H, Larson SM, et al. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 1999;84(7):2291-302.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, Issue.7
, pp. 2291-2302
-
-
Wang, W.1
Macapinlac, H.2
Larson, S.M.3
-
100
-
-
0028848228
-
Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide
-
Scott GC, Meier DA, Dickinson CZ. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide. J Nucl Med 1995;36(10):1843-5.
-
(1995)
J Nucl Med
, vol.36
, Issue.10
, pp. 1843-1845
-
-
Scott, G.C.1
Meier, D.A.2
Dickinson, C.Z.3
-
101
-
-
0027441026
-
Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy
-
Sisson JC, Ackermann RJ, Meyer MA, et al. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy. J Clin Endocrinol Metab 1993;77(4):1090-4.
-
(1993)
J Clin Endocrinol Metab
, vol.77
, Issue.4
, pp. 1090-1094
-
-
Sisson, J.C.1
Ackermann, R.J.2
Meyer, M.A.3
-
102
-
-
0033457279
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
-
Grunwald F, Kalicke T, Feine U, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999;26(12):1547-52.
-
(1999)
Eur J Nucl Med
, vol.26
, Issue.12
, pp. 1547-1552
-
-
Grunwald, F.1
Kalicke, T.2
Feine, U.3
-
103
-
-
0031663858
-
Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer
-
Schluter B, Grimm-Riepe C, Beyer W, et al. Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer. Langenbecks Arch Surg 1998;383(2):187-9.
-
(1998)
Langenbecks Arch Surg
, vol.383
, Issue.2
, pp. 187-189
-
-
Schluter, B.1
Grimm-Riepe, C.2
Beyer, W.3
-
104
-
-
0029855907
-
Detection of circulating thyroid cells in peripheral blood
-
Ditkoff BA, Marvin MR, Yemul S, et al. Detection of circulating thyroid cells in peripheral blood. Surgery 1996;120(6):959-64.
-
(1996)
Surgery
, vol.120
, Issue.6
, pp. 959-964
-
-
Ditkoff, B.A.1
Marvin, M.R.2
Yemul, S.3
-
105
-
-
0031934340
-
Detection of thyroglobulin, thyroid peroxidase, and RET/PTC-1 mRNA transcripts in the peripheral blood of patients with thyroid disease
-
Tallini G, Ghossein RA, Emanuel J, et al. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC-1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 1998;16(3):1148-66.
-
(1998)
J Clin Oncol
, vol.16
, Issue.3
, pp. 1148-1166
-
-
Tallini, G.1
Ghossein, R.A.2
Emanuel, J.3
-
106
-
-
0032461020
-
Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood
-
Ringel MD, Ladenson PW, Levine MA, et al. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998;83(12):4435-42.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, Issue.12
, pp. 4435-4442
-
-
Ringel, M.D.1
Ladenson, P.W.2
Levine, M.A.3
-
107
-
-
0032992176
-
Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects
-
Wingo ST, Ringel MD, Anderson JS, et al. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 1999;45(6 pt 1):785-9.
-
(1999)
Clin Chem
, vol.45
, Issue.6 PART 1
, pp. 785-789
-
-
Wingo, S.T.1
Ringel, M.D.2
Anderson, J.S.3
-
108
-
-
0033323803
-
Quantitative reverse transcriptionpolymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma
-
Ringel MD, Balducci-Silano PL, Anderson JS, et al. Quantitative reverse transcriptionpolymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 1999;84(11):4037-42.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, Issue.11
, pp. 4037-4042
-
-
Ringel, M.D.1
Balducci-Silano, P.L.2
Anderson, J.S.3
-
109
-
-
0027282562
-
Surgical reintervention for differentiated thyroid cancer
-
Goretzki PE, Simon D, Frilling A, et al. Surgical reintervention for differentiated thyroid cancer. Br J Surg 1993;80(8):1009-12.
-
(1993)
Br J Surg
, vol.80
, Issue.8
, pp. 1009-1012
-
-
Goretzki, P.E.1
Simon, D.2
Frilling, A.3
-
110
-
-
0028302371
-
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131)
-
Coburn M, Teates D, Wanebo HJ. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg 1994;19(6):587-93.
-
(1994)
Ann Surg
, vol.19
, Issue.6
, pp. 587-593
-
-
Coburn, M.1
Teates, D.2
Wanebo, H.J.3
-
111
-
-
0026561556
-
Management of local recurrence in welldifferentiated thyroid carcinoma
-
Hamby LS, McGrath PC, Schwartz RW, et al. Management of local recurrence in welldifferentiated thyroid carcinoma. J Surg Res 1992;52(2):113-7.
-
(1992)
J Surg Res
, vol.52
, Issue.2
, pp. 113-117
-
-
Hamby, L.S.1
McGrath, P.C.2
Schwartz, R.W.3
-
112
-
-
0030958526
-
The surgical management of laryngotracheal invasion by welldifferentiated papillary thyroid carcinoma
-
Czaja JM, McCaffrey TV. The surgical management of laryngotracheal invasion by welldifferentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 1997;123(5):484-90.
-
(1997)
Arch Otolaryngol Head Neck Surg
, vol.123
, Issue.5
, pp. 484-490
-
-
Czaja, J.M.1
McCaffrey, T.V.2
-
113
-
-
0027933714
-
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
-
Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994;18(4):600-4.
-
(1994)
World J Surg
, vol.18
, Issue.4
, pp. 600-604
-
-
Pacini, F.1
Cetani, F.2
Miccoli, P.3
-
114
-
-
0026769603
-
Radioiodine-131 therapy for welldifferentiated thyroid cancer-a quantitative radiation dosimetric approach: Outcome and validation in 85 patients
-
Maxon HR, Englaro EE, Thomas SR, et al. Radioiodine-131 therapy for welldifferentiated thyroid cancer-a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992;33(6):1132-6.
-
(1992)
J Nucl Med
, vol.33
, Issue.6
, pp. 1132-1136
-
-
Maxon, H.R.1
Englaro, E.E.2
Thomas, S.R.3
-
115
-
-
12244293919
-
I-131 therapy for thyroid cancer: Quantitative dosimetric approach- outcome and validation in 85 patients
-
Maxon HR, Englaro EE, Thomas SR, et al. I-131 therapy for thyroid cancer: quantitative dosimetric approach- outcome and validation in 85 patients. J Nucl Med 1992;33(5):894.
-
(1992)
J Nucl Med
, vol.33
, Issue.5
, pp. 894
-
-
Maxon, H.R.1
Englaro, E.E.2
Thomas, S.R.3
-
116
-
-
0027016650
-
Prognostic factors in differentiated carcinoma of the thyroid gland
-
Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164(6):658-61.
-
(1992)
Am J Surg
, vol.164
, Issue.6
, pp. 658-661
-
-
Shah, J.P.1
Loree, T.R.2
Dharker, D.3
-
117
-
-
0024239072
-
Radioiodine therapy for differentiated thyroid carcinoma
-
Connor CS, Thomas JH, Robinson RG, et al. Radioiodine therapy for differentiated thyroid carcinoma. Am J Surg 1988;156(6):519-21.
-
(1988)
Am J Surg
, vol.156
, Issue.6
, pp. 519-521
-
-
Connor, C.S.1
Thomas, J.H.2
Robinson, R.G.3
-
118
-
-
0019880402
-
131I therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience
-
131I therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience. Cancer 1981;47(4):664-71.
-
(1981)
Cancer
, vol.47
, Issue.4
, pp. 664-671
-
-
Maheshwari, Y.K.1
Hill, C.S.2
Haynie T.P. III3
-
119
-
-
0027429811
-
Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
-
Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993;34(10):1626-31.
-
(1993)
J Nucl Med
, vol.34
, Issue.10
, pp. 1626-1631
-
-
Casara, D.1
Rubello, D.2
Saladini, G.3
-
120
-
-
0030119620
-
Radioactive iodine treatment and external radiotherapy for long bone metastases from thyroid carcinoma
-
Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for long bone metastases from thyroid carcinoma. J Nucl Med 1996;37(4):598-605.
-
(1996)
J Nucl Med
, vol.37
, Issue.4
, pp. 598-605
-
-
Schlumberger, M.1
Challeton, C.2
De Vathaire, F.3
-
121
-
-
0024380917
-
Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma
-
Marcocci C, Pacini F, Elisei R, et al. Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989;106(6):960-6.
-
(1989)
Surgery
, vol.106
, Issue.6
, pp. 960-966
-
-
Marcocci, C.1
Pacini, F.2
Elisei, R.3
-
122
-
-
0021333920
-
Radioiodine treatment of metastatic thyroid carcioma: The Royal Marsden Hospital experience
-
Brown AP, Greening WP, McCready VR, et al. Radioiodine treatment of metastatic thyroid carcioma: the Royal Marsden Hospital experience. Br J Radiol 1984;57(676):323-7.
-
(1984)
Br J Radiol
, vol.57
, Issue.676
, pp. 323-327
-
-
Brown, A.P.1
Greening, W.P.2
McCready, V.R.3
-
123
-
-
0021354928
-
Pulmonary metastases in differentiated thyroid carcinoma
-
Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma. Cancer 1984;53(4):982-92.
-
(1984)
Cancer
, vol.53
, Issue.4
, pp. 982-992
-
-
Massin, J.P.1
Savoie, J.C.2
Garnier, H.3
|